NCT Number: NCT00468754
A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine
This trial will compare the metabolic control in type 1 diabetes obtained by continuous infusion of insulin lispro with that obtained by multiple daily injections of insulin lispro and glargine, a long-acting insulin analogue. Patients will be switched to the alternative treatment after 4 months. Glucose variability in the last month of each treatment will be analyzed.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–60 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Bergamo, Italy
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Type 1 diabetic patients, 18-60 years of age
- Diabetic for >2 years
- Treated with CSII for >=6 months
- HbA1c <8.5%
Exclusion criteria
- Treatment with daily insulin injections
- Inability to handle pump therapy
- Untreated retinopathy
Treatment and study plan
Primary outcomes
-
Variability of blood glucose characterised by the standard deviation of the mean blood glucose
Time frame: Length of study
Secondary outcomes
-
HbA1c
Time frame: Length of study
-
Mean BG during the last month of the respective treatment period
Time frame: Length of study
-
Frequency of severe hypoglycemia
Time frame: Length of study
-
Daily insulin requirement
Time frame: Length of study
Sponsors and collaborators
Lead sponsor
Hoffmann-La Roche
Industry
Registry information
Important dates
- Study start
- 2003
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- May 3, 2007
- Registry last updated
- Mar 3, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes
NCT02624804
Autoimmune Diseases, Diabetes Mellitus
Hackensack, New Jersey, United States
View Trial DetailsReal-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop
NCT07015970
Autoimmune Diseases, Diabetes Mellitus
Caen, France
View Trial DetailsFeasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry
NCT06088615
Autoimmune Diseases, Diabetes Mellitus
Ulm, Baden-Wurttemberg, Germany
View Trial DetailsSolitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
NCT00006505
Autoimmune Diseases, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial Details